Previous Close | 33.66 |
Open | 33.59 |
Bid | 34.56 x 100 |
Ask | 34.64 x 100 |
Day's Range | 33.16 - 35.36 |
52 Week Range | 19.80 - 35.50 |
Volume | |
Avg. Volume | 763,814 |
Market Cap | 1.963B |
Beta (5Y Monthly) | 0.86 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -6.33 |
Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 42.80 |
Agios Pharmaceuticals showcases a strong Q1 with significant progress in clinical trials and a solid cash reserve, setting the stage for future growth.
Q1 2024 Agios Pharmaceuticals Inc Earnings Call
Key Financial Highlights and Strategic Developments in Rare Disease Therapeutics